First evidence of activity of enfortumab vedotin on brain metastases in urothelial cancer patients

Bron
Pharmaceuticals - ISSN 1424-8247-16:3 (2023) p. 1-8
Auteur(s)

POLRMT as a novel susceptibility gene for cardiotoxicity in epirubicin treatment of breast cancer patients

Bron
Pharmaceutics - ISSN 1999-4923-13:11 (2021) p.
Auteur(s)
    Alejandro Velasco-Ruiz, Rocio Nunez-Torres, Guillermo Pita, Hans Wildiers, Diether Lambrechts, Sigrid Hatse, Danielle Delombaerde, Thomas Van Brussel, M. Rosario Alonso, Nuria Alvarez, Belen Herraez, Christof Vulsteke, Pilar Zamora, Teresa Lopez-Fernandez, Anna Gonzalez-Neira